PCR Trials: EVOLUTE II - 5-year

EuroIntervention Journal

Consult the selected trial on 'Thin-strut, bioresorbable polymer-coated EES: EVOLUTE II – 5 years' by Kereiakes et al.

The objective of this trial was to report the 5-year clinical adverse event rate of the Synergy stent (thin-strut, bioresorbable polymer-coated everolimus-eluting stents) compared to Promus Element Plus stent.

Discover the trial

Authors

Kereiakes et al. Circulation Cardiovasc Interv. 2019;12:e008152